Kaur M et al., Nature Communications - Reconstitution of asymmetric membranes and matched cell experiments show that transbilayer asymmetry of PI(4,5)P2 lowers the energetic barrier for FGF2-driven lipidic pore formation and enables rapid unconventional secretion. Disrupting PI(4,5)P2 asymmetry in cells blocks FGF2 export. Key terms: FGF2, PI(4,5)P2, membrane asymmetry, unconventional secretion, lipidic pore.
Study Highlights:
The authors created asymmetric LUVs and GUVs by enzymatic conversion of outer-leaflet PI(4)P to PI(4,5)P2 using PIP5K1C. Time-lapse GUV assays showed that PI(4,5)P2 asymmetry accelerated FGF2-dependent lipidic pore formation (mean ≈45 min asymmetric vs ≈95 min symmetric). In CHO-K1 cells, delivering PI(4,5)P2 to the outer leaflet to disturb asymmetry prevented reappearance of surface FGF2-GFP after heparin wash. Addition of other FGF2-binding phosphoinositides (PI(3,4)P2, PI(3,4,5)P3) similarly inhibited secretion, while PI(4)P and PS did not.
Conclusion:
Transbilayer asymmetry of PI(4,5)P2 is a key biophysical determinant that facilitates FGF2 oligomer–dependent lipidic pore formation and efficient unconventional secretion.
Music:
Enjoy the music based on this article at the end of the episode.
Article title:
Plasma membrane transbilayer asymmetry of PI(4,5)P2 drives unconventional secretion of Fibroblast Growth Factor 2
First author:
Kaur M
Journal:
Nature Communications
DOI:
10.1038/s41467-025-66860-z
Reference:
Kaur M, Lolicato F, Nickel W. Plasma membrane transbilayer asymmetry of PI(4,5)P2 drives unconventional secretion of Fibroblast Growth Factor 2. Nat Commun (2025). https://doi.org/10.1038/s41467-025-66860-z
License:
Creative Commons Attribution 4.0 International (CC BY 4.0)
Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00
Official website https://basebybase.com
On PaperCast Base by Base you’ll discover the latest in genomics, functional genomics, structural genomics, and proteomics.
Episode link: https://basebybase.com/episodes/pi45p2-asymmetry-drives-fgf2-secretion
QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-11-30.
QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited the transcript's coverage of PI(4,5)P2 transbilayer asymmetry driving FGF2 secretion, including in vitro asymmetric membranes (LUVs/GUVs), kinase-driven outer-leaflet PI(4,5)P2 generation, cell-based disruption of asymmetry and secretion, lipid controls, kinetics, and recovery dynamics.
- transcript topics: FGF2 unconventional secretion overview; PI(4,5)P2 transbilayer asymmetry concept; In vitro reconstitution with asymmetric LUVs/GUVs; PIP5K1C-mediated outer-leaflet PI(4,5)P2 generation and asymmetry verification; Kinetics of FGF2 pore formation in asymmetric vs symmetric membranes; Cell-based disruption of PI(4,5)P2 asymmetry and impact on FGF2 secretion
QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 6
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0
Metadata Audited:
- article_doi
- article_title
- article_journal
- license
Factual Items Audited:
- Core mechanism: PI(4,5)P2 transbilayer asymmetry lowers energy barrier for FGF2 membrane pore formation.
- In vitro, asymmetric PI(4,5)P2 on outer leaflet accelerates pore formation (GUVs) compared with symmetric membranes.
- Cell-based disruption of PI(4,5)P2 asymmetry inhibits FGF2 secretion.
- Controls show PS and PI(4)P do not inhibit secretion; PI(3,4)P2 and PI(3,4,5)P3 do inhibit secretion.
- GPC1 captures FGF2 after pore formation, enabling extracellular release.
- Kinetics: asymmetric GUVs show ~45 min pore-formation time vs ~95 min for symmetric; cells show ~30 min acute secretion window after heparin wash; recovery occurs as outer-leaflet
QC result: Pass.
Fler avsnitt av Base by Base
Visa alla avsnitt av Base by BaseBase by Base med Gustavo Barra finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
